Johnson & Johnson announced a $1 billion investment to up their capacity to make 1 billion doses of the Coronavirus vaccine. Part of the deal will include $421 million from the United States government.
Johnson & Johnson stated that they have picked their leading candidate for the vaccine and plan to start human testing in September.
The company currently has a manufacturing site in the Netherlands that could manufacture 300 million doses.
